Role of immunoglobulin a monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection

Infection and Immunity

Volumn 66, Issue 9, 1998, Pages 4469-4473

  Javier Enriquez, F ^a   Riggs, Michael W ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; MONOCLONAL ANTIBODY; PARASITE ANTIGEN; PROTEIN P23; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG EFFICACY; ELECTROPHORETIC MOBILITY; HYBRIDOMA; IMMUNOPROPHYLAXIS; INTESTINE INFECTION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PASSIVE IMMUNIZATION; PEYER PATCH; PRIORITY JOURNAL;

EID: 3543022665     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/.66.9.4469-4473.1998     Document Type: Article

References (46)

1. Arrowood, M. J., J. R. Mead, J. L. Mahrt, and C. R. Sterling. 1989. Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of Cryptosporidium parvum infections in neonatal mice. Infect. Immun. 57:2283-2288.
2. Arrowood, M. J., and C. R. Sterling. 1987. Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J. Parasitol. 73:314-319.
3. Arrowood, M. J., C. R. Sterling, and M. C. Healey. 1991. Immunofluorescent microscopical visualization of trails left by gliding Cryptosporidium parvum sporozoites. J. Parasitol. 77:315-317.
4. Banhamou, Y., N. Kapal, C. Hoang, H. Matta, D. Meillet, D. Magne, M. Raphael, M. Gentilini, P. Opolon, and J. G. Gobert. 1995. Inefficacy of intestinal secretory immune response to Cryptosporidium in acquired immunodeficiency syndrome. Gastroenterology 108:627-635.
5. Bjorneby, J. M., B. D. Hunsaker, M. W. Riggs, and L. E. Perryman. 1991. Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum. Infect. Immun. 59:1172-1176.
6. Blagburn, B. L., and R. Soave. 1997. Prophylaxis and chemotherapy, p. 111-128. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Inc., Boca Raton, Fla.
7. Bouche, H., C. Housset, J. Dumont, F. Carnot, Y. Menu, B. Aveline, J. Belghiti, B. Boboc, S. Erlinger, P. Berthelot, and S. Pol. 1993. AIDS-related cholangitis: diagnostic features and courses in 15 patients. J. Hepatol. 17:34-39.
8. Burns, J. W., M. Siadat-Pajouh, A. A. Krishnaney, and H. B. Greenberg. 1996. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272:104-107.
9. Cama, V. A., and C. R. Sterling. 1991. Hyperimmune hens as a novel source of anti-Cryptosporidium antibodies suitable for passive immune transfer. J. Protozool. 38:42s-43s.
10. Cozon, G., F. Biron, M. Jeannin, D. Cannella, and J. P. Revillard. 1994. Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis. J. Infect. Dis. 169:696-699.
11. Enriquez, F. J., D. Bradley-Dunlop, and L. Joens. 1991. Increased proportion of antigen-specific antibody-producing hybridomas following an in vitro immunization with in vivo immunized mouse spleen cells. Hybridoma 10: 745-751.
12. 11a.Enriquez, F. J. Unpublished data.
13. Fayer, R., L. E. Perryman, and M. W. Riggs. 1989. Hyperimmune bovine colostrum neutralizes Cryptosporidium sporozoites and protects mice against oocyst challenge. Infect. Immun. 75:151-153.
14. Fayer, R., C. A. Speer, and J. P. Dubey, 1997. The general biology of Cryptosporidium, p. 1-42. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Inc., Boca Raton, Fla.
15. Flanigan, T. P. 1994. Human immunodeficiency virus infection and cryptosporidiosis: protective immune responses. Am. J. Trop. Med. Hyg. 50:S29-S35.
16. Godwin, T. A. 1991. Cryptosporidiosis in the acquired immunodeficiency syndrome: a study of 15 autopsy cases. Hum. Pathol. 22:1215-1224.
17. Gut, J. M., and R. G. Nelson. 1994. Cryptosporidium parvum sporozoites deposit trails of 11A5 antigen during gliding locomotion and shed 11A5 antigen during invasion of MDCK cells in vitro. J. Eukaryot. Microbiol. 41:42S.
18. Krachenbuhl, J. P., and M. Neutra. 1992. Transepithelial transport and mucosal defense: secretion of IgA. Trends Curr. Biol. 2:170-174.
19. Lockwood, D. N. J., and J. N. Weber. 1989. Parasite infections in AIDS. Parasitol. Today 5:310-315.
20. Mazanec, M. B., J. G. Nedruc, and M. E. Lamm. 1987. Immunoglobulin A monoclonal antibodies protect against Sendai virus. J. Virol. 61:2624-2626.
21. McGowan, I. 1993. The natural history of cryptosporidial diarrhoea in HIV-infected patients. AIDS 7:349-354.
22. Mead, J. R., M. J. Arrowood, and C. R. Sterling. 1988. Antigens of Cryptosporidium sporozoites recognized by immune sera of infected animals and humans. J. Parasitol. 74:135-143.
23. Michetti, P., M. J. Mahan, J. M. Slauch, J. J. Mekalanos, and M. Neutra. 1992. Monoclonal secretory IgA protects mice against oral challenge with the invasive pathogen Salmonella typhimuriiim. Infect. Immun. 60:1786-1792.
24. Neutra, M. R., P. Michetti, and J. P. Kraehenbuhl. 1994. Secretory immunoglobulin A. Induction, biogenesis and function, p. 685-708. In L. R. Johnson (ed.), Physiology of the gastrointestinal tract. Raven Press, New York, N.Y.
25. Nord, J. M. P., D. DiJohn, S. Tzipori, and C. O. Tacket. 1990. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 4:581-584.
26. Perryman, L. E., and J. M. Bjorneby. 1991. Immunotherapy of cryptosporidiosis in immunodeficient animal models. J. Protozool. 38:98S-100S.
27. Perryman, L. E., D. P. Jasmer, M. W. Riggs, S. G. Bohnet, T. C. McGuire, and M. J. Arrowood. 1996. A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes. Mol. Biochem. Parasitol. 80:137-147.
28. Perryman, L. E., M. W. Riggs, P. H. Mason, and R. Fayer. 1990. Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum. Infect. Immun. 58: 257-259.
29. Petersen, C. 1992. Cryptosporidiosis in patients infected with the human immunodeficiency virus. Clin. Infect. Dis. 15:903-909.
30. Renegar, K. B., and P. A. J. Small. 1991. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146:1972-1978.
31. Reperant, J. M., M. Naciri, T. Chardes, and D. T. Bout. 1992. Immunological characterization of a 17-kDa antigen from Cryptosporidium parvum recognized early by mucosal IgA antibodies. Fed. Eur. Microbiol. Soc. Microbiol. Lett. 99:7-14.
32. Riggs, M. W. 1997. Immunology: host response and development of passive immunotherapy and vaccines, p. 129-162. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Inc., Boca Raton, Fla.
33. Riggs, M. W., V. A. Cama, H. L. Leary, Jr., and C. R. Sterling. 1994. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect. Immun. 62:1927-1939.
34. Riggs, M. W., and L. E. Perryman. 1987. Infectivity and neutralization of Cryptosporidium parvum sporozoites. Infect. Immun. 55:2081-2087.
35. Riggs, M. W., A. L. Stone, P. A. Yount, R. C. Langer, M. J. Arrowood, and D. L. Bentley. 1997. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites. J. Immunol. 158:1787-1795.
36. Snedecor, G. W., and W. G. Cochran. 1980. Statistical methods, p. 3-159. Iowa State University Press, Ames.
37. Tarazona, R., N. C. Lally, M. Dominguez-Carmona, and D. A. Blewett. 1997. Characterization of IgA responses in mice infected with Cryptosporidium parvum. Int. J. Parasitol. 27:417-423.
38. Tilley, M., S. E. Upton, R. Fayer, J. R. Barta, C. E. Chrisp, P. S. Freed, B. L. Blagburn, B. C. Anderson, and S. M. Barnard. 1991. Identification of a 15-kilodakon surface glycoprotein on sporozoites of Cryptosporidium parvum. Infect. Immun. 59:1002-1007.
39. Tilley, M., and S. J. Upton. 1994. Both CP15 and CP25 are left as trails behind gliding sporozoites of Cryptosporidium parvum (apicomplexa). Fed. Eur. Microbiol. Soc. Microbiol. Lett. 120:275-278.
40. Tzipori, S., D. Roberton, and C. Chapman. 1986. Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. Br. Med. J. 293:1276-1277.
41. Tzipori, S., D. Roberton, D. A. Cooper, and L. White. 1987. Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet ii:344-347.
42. Ungar, B. L. P. 1990. Cryptosporidiosis in humans (Homo sapiens), p. 59-82. In J. P. Dubey, R. Fayer, and C. A. Speer (ed.), Cryptosporidiosis in man and animals. CRC Press, Inc., Baton Rouge, La.
43. Ungar, B. L. P., D. J. Ward, R. Fayer, and C. A. Quinn. 1990. Cessation of Cryptosporidium associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology 98:486-489.
44. Vakil, N. B., S. M. Schwartz, B. P. Buggy, C. P. Brummitt, M. Kherellah, D. M. Letzer, I. H. Gilson, and P. G. Jones. 1996. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N. Engl. J. Med. 334:19-23.
45. Winner, L. S., J. Mack, R. A. Weltzin, J. J. Mekalanos, J. P. Kraehenbuhl, and M. R. Neutra. 1991. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect. Immun. 59: 977-982.
46. Zu, S. X., G. D. Fang, R. Fayer, and R. L. Guerrant. 1992. Cryptosporidiosis: pathogenesis and immunology. Parasitol. Today 8:24-27.